Alen Lovrić

This study uses CeTEAM biosensors to profile PARP inhibitor selectivity at the single-cell level, revealing PARP1 and PARP2 selectivity patterns and the role of HPF1 in drug binding.

RMetD2 integrates differentially expressed genes into genome-scale metabolic models to reveal metabolic differences between conditions, outperforming existing methods in capturing experimentally observed features.